CNSX:PREVPreveceutical Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Preveceutical Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range$0.03MA: $0.04▼$0.0652-Week Range N/AVolume694,224 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines PreveCeutical Medical Inc., a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products. It has research and development programs, including dual gene therapy for curative and prevention therapies for diabetes and obesity; the Program; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions. The company offers CELLB9 immune system booster, an oral solution containing polarized and potentiated essential minerals extracted from a peptide obtained from Caribbean blue scorpion venom. It also provides medicinal cannabis-based products. The company has a research and option agreement with University of Queensland; and the UniQuest Pty Limited to develop non-addictive analgesics for the treatment of pain. It also has a strategic research and development supply agreement with Aurora Cannabis to produce medical cannabis. PreveCeutical Medical Inc. is based in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Preveceutical Medical. Previous Next 3.2 Community Rank Outperform VotesPreveceutical Medical has received 23 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPreveceutical Medical has received 13 “underperform” votes. (Add your “underperform” vote.)Community SentimentPreveceutical Medical has received 63.89% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Preveceutical Medical and other stocks. Vote “Outperform” if you believe PREV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PREV will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldPreveceutical Medical does not currently pay a dividend.Dividend GrowthPreveceutical Medical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Preveceutical Medical insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.64 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCNSX:PREV Previous Symbol CUSIPN/A CIKN/A Webwww.preveceutical.com Phone604-416-7777Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable TSXV:PREV Rates by TradingView Receive PREV News and Ratings via Email Sign-up to receive the latest news and ratings for PREV and its competitors with MarketBeat's FREE daily newsletter. Preveceutical Medical (CNSX:PREV) Frequently Asked Questions Has Preveceutical Medical been receiving favorable news coverage? Media headlines about PREV stock have trended very negative on Sunday, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Preveceutical Medical earned a media sentiment score of -3.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Preveceutical Medical. Who are some of Preveceutical Medical's key competitors? Some companies that are related to Preveceutical Medical include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Admedus (AHZ), Almirall (LBTSF), Amarantus Bioscience (AMBS), Antibe Therapeutics (VBIZF), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Baudax Bio (BXRXV), BerGenBio ASA (BRRGF), Biocure Technology (CURE), Canada House Wellness Group (CHV) and Cannabics Pharmaceuticals (CNBX). View all competitors. What other stocks do shareholders of Preveceutical Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Preveceutical Medical investors own include Aurora Cannabis (ACB), Equinix (EQIX), Bank of Nova Scotia (BNS), Biocept (BIOC), Baidu (BIDU), BlackBerry (BB), Alimentation Couche-Tard (ATD.B), Aphria (APHA), Amarin (AMRN) and Advanced Micro Devices (AMD). Who are Preveceutical Medical's key executives? Preveceutical Medical's management team includes the following people: Mr. Stephen Van Deventer, Chairman & CEO (Age 50)Dr. Makarand Jawadekar Ph.D., Chief Science Officer, Pres & Director (Age 68)Ms. Shabira Rajan CPA, CGA, CFO & Controller (Age 63)Ms. Deanna Kress, Director of Corp. Communications & Investor RelationsMs. Alicia Rebman, Marketing Director (Age 42) What is Preveceutical Medical's stock symbol? Preveceutical Medical trades on the CNSX under the ticker symbol "PREV." How do I buy shares of Preveceutical Medical? Shares of PREV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Preveceutical Medical's official website? The official website for Preveceutical Medical is www.preveceutical.com. How can I contact Preveceutical Medical? The company can be reached via phone at 604-416-7777. This page was last updated on 7/12/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
